Form 4 for ELAN Elanco Animal Health Inc
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001415889-22-002471 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | ELAN | Kinard David S | SEE REMARKS | A - Grant | $0.00 | +8,665 | 97.2K | +10% | $0 |
| DM | 2022-03-03 | 2022-03-01+ | ELAN | Kinard David S | SEE REMARKS | F - Tax | $28.96 | -2,598 | 94.6K | -3% | -$75.2K |
| D | 2022-03-03 | 2022-03-01 | ELAN | Kinard David S | SEE REMARKS | A - Grant | $0.00 | +23.0K | 23.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-01 | A | A | 8,665 | $0.00 | 97,241 | D | — | — | (F1) Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2022, one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. |
| 2 | Common | Common Stock | 2022-03-01 | F | D | 1,724 | $28.94 | 95,517 | D | — | — | (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan |
| 3 | Common | Common Stock | 2022-03-02 | F | D | 874 | $29.00 | 94,643 | D | — | — | (F2) Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan |
| 4 | Derivative | Employee Stock Option(right to buy) | 2022-03-01 | A | A | 23,026 | $0.00 | 23,026 | D | $28.94 · — to 2032-03-01 | 23,026 Common Stock | (F3) Grant of stock options vesting as follows: one-third vesting on March 1, 2023, one-third vesting on March 1, 2024, and the remaining vesting on March 1, 2025. |